NCT06718647View on ClinicalTrials.gov

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Prostate Cancer Metastatic Disease
Trial Locations (1)

16128

Ente Ospedaliero Ospedali Galliera, Genoa

All Listed Sponsors
lead

Monica Boitano

OTHER